Assessment of the effects of topical post-operative administration of nepafenac 0.1% eye drops on occurrence of macular edema in patient undergoing cataract surgery
Not Applicable
- Conditions
- Health Condition 1: H358- Other specified retinal disorders
- Registration Number
- CTRI/2023/03/050910
- Lead Sponsor
- A Mohamed shakil
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Patient with senile cataract more than 50 years of age.
Exclusion Criteria
Patient with anterior segment pathology (corneal opacities, pseudo exfoliation syndrome and dense cataract interfering with OCT imaging); patient with traumatic or complicated cataract history of topical or systemic NSAID use prior to surgery, allergy or hypersensitivity to NSAIDs, previous ocular surgery, amblyopia, retinal abnormalities, connective tissue disease, diabetes mellitus, steroid, or immunosuppressive treatment, and any intraoperative or postoperative complication.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To evaluate the effect of topical postoperative administration of nepafenac 0.1% eye drops on occurrence of macular edema in patient undergoing uncomplicated cataract surgeryTimepoint: 6 weeks
- Secondary Outcome Measures
Name Time Method To emphazize the importance of obtaining optimum visual acuity by preventing cystoid macular edemaTimepoint: 6 weeks